{
  "folder": "IC-075",
  "content": "{{knowledge objective\n|Identifiant=OIC-075-31-B\n|Item_parent=Smoking addiction\n|Item_parent_short=Smoking addiction\n|Rank=B\n|Title=Knowing about medication other than nicotine replacement therapy\n|Description=Varenicline and Bupropion\n|Rubric=Management\n|Contributors=\n|Order=31}}\nAfter nicotine replacement therapy, Varenicline can be offered as a second-line treatment, followed by Bupropion as a last-line treatment.\n\n'''Varenicline''' :\n\n* Partial agonist of nicotinic acetylcholine receptors.\n* Indicated in cases of failure of nicotine replacement therapy and strong nicotine dependence.\n* The main side effects are nausea, headaches, nightmares, insomnia, depression and cardiovascular risk.\n* Reimbursed by health insurance\n\n'''Bupropion''' :\n\n* Noradrenaline and dopamine reuptake inhibitor\n\n<br />",
  "question": {
    "question": "Which of the following statements about Varenicline is correct?",
    "option_a": "Varenicline is a full agonist of nicotinic acetylcholine receptors.",
    "option_b": "Varenicline is indicated in cases of mild nicotine dependence.",
    "option_c": "The main side effects of Varenicline include nausea, headaches, nightmares, insomnia, depression, and cardiovascular risk.",
    "option_d": "Varenicline is not reimbursed by health insurance.",
    "correct_option": "C"
  }
}